Since its beginning in early 2019, the ICPO Foundation has already received financial and active personal support from a growing community of internationally acclaimed experts, philanthropists, leading medical and industrial entities, and governmental institutions around the globe.
The ICPO Foundation is honored to be able to celebrate its official inauguration together with the 20th anniversary of Targeted Isotope Therapy in Bad Berka and would in this context like to extend an open invitation to all participants and the emerging international community in Precision Oncology to participate, contribute to, and benefit from its mission to globally expand and continously improve Best Practices and Patient Access in Precison Oncology.
